Jeffrey H. Schwartz, PhD
- 2Articles
- 9.6KReads1
- 2010–2011Active
- 10Collaborators
- 203Citations2
About
Jeffrey H. Schwartz, PhD, has published research on the treatment of Bipolar I Disorder, focusing on the efficacy and safety of adjunctive oral ziprasidone for acute depression and its use combined with mood stabilizers. His work includes randomized, double-blind, placebo-controlled trials conducted between 2010 and 2011. Schwartz has frequently collaborated with co-authors such as Kathleen S. Ice, Bryce Kasuba, Charles L. Bowden, Douglas G. Vanderburg, and Eduard Vieta.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
